Golden Stone Asia Pharmacy: Net profit increased by 67.71% year-on-year in the first half of 2025.

Jinshi Asia Pharmaceutical announced that its operating income in the first half of 2025 was 492 million yuan, a year-on-year decrease of 5.80%. Net profit was 65.7454 million yuan, a year-on-year increase of 67.71%.